Where Will Celsius Stock Be in 5 Years?

Celsius is still growing, with brand revenue up 7.5% year over year in Q4 2025 and Alani Nu retail sales up 76.9% in the 13 weeks ended Dec. 28, 2025, but growth is slowing and competition is intense. The stock trades at 22.5x 2026 consensus EPS, and the article warns that future returns depend on earnings growth continuing while the valuation multiple holds up. Market share remains 19.8%, well behind Red Bull at 35.9% and Monster at 27.3%.

Analysis

CELH still screens as a growth asset, but the market is now paying for an outcome that requires both sustained sell-through and stable category economics. The bigger second-order issue is that energy drinks are becoming a category where distribution access, shelf resets, and promotional intensity matter more than pure consumer preference; that tends to compress margins and keeps winners from compounding at the same rate as earlier category expansions.

The real pressure point is not demand, it is normalization. If private label and incumbent response keep widening the price/pack architecture, CELH can retain share but lose the ability to expand gross profit per point of revenue, which is what ultimately matters at a mid-20s forward multiple. That creates a subtle trap: reported revenue can look fine while earnings revisions stall, and the market typically re-rates these names before absolute growth turns negative.

COST is the cleanest beneficiary of any private-label share capture because it can weaponize traffic and price perception without needing branded loyalty. MNST is the more interesting relative short on a 6-12 month horizon: it has the balance sheet and distribution scale to defend, but if CELH’s premium niche is structurally challenged, category growth may not be enough to support both multiple and mix. The contrarian point is that the stock may already be pricing in too much deceleration; if Alani Nu actually broadens demographic reach and retailer support stays intact, CELH can still surprise on earnings even with slower top-line growth.

Key Decisions for Investors

• Avoid initiating new long CELH positions here; wait for either a post-earnings reset or a valuation trough closer to a mid-teens forward EPS multiple, since the current setup depends on multiple stability that is unlikely in a maturing category.
• Pair trade: long COST / short CELH over the next 3-6 months to express private-label and traffic-leverage benefits versus a higher-beta branded beverage name with more multiple compression risk.
• Consider long MNST / short CELH as a relative-value hedge over 6-12 months if channel checks show price promotions intensifying; MNST is better positioned to defend shelf space and absorb promotional pressure.
• For higher risk tolerance, buy CELH downside protection into the next earnings event: buy 3-6 month puts or put spreads to capture the risk that earnings merely meet estimates while the multiple de-rates.
• If CELH gaps down on a short-term selloff without an earnings cut, use that as a tactical entry only after confirming retailer support and no further share-loss in Circana-style data.